Stock Research for ARNA


Featured Broker: Ally Invest

Get the due diligence for another stock.


ARNA Stock Chart & Research Data

The ARNA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ARNA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ARNA Due diligence Resources & Stock Charts

The ARNA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ARNA Detailed Price Forecast - CNN Money CNN View ARNA Detailed Summary - Google Finance
Yahoo View ARNA Detailed Summary - Yahoo! Finance Zacks View ARNA Stock Research & Analysis -

Stock Analysis

TradeIdeas View ARNA Trends & Analysis - Trade-Ideas Barrons View ARNA Major Holders - Barrons
NASDAQ View ARNA Call Transcripts - NASDAQ Seeking View ARNA Breaking News & Analysis - Seeking Alpha
Spotlight View ARNA Annual Report - OTC Report View ARNA OTC Short Report -
TradeKing View ARNA Fundamentals - TradeKing Charts View ARNA SEC Filings - Bar Chart
WSJ View Historical Prices for ARNA - The WSJ Morningstar View Performance/Total Return for ARNA - Morningstar
MarketWatch View the Analyst Estimates for ARNA - MarketWatch CNBC View the Earnings History for ARNA - CNBC
StockMarketWatch View the ARNA Earnings - StockMarketWatch MacroAxis View ARNA Buy or Sell Recommendations - MacroAxis
Bullish View the ARNA Bullish Patterns - American Bulls Short Pains View ARNA Short Pain Metrics -

Social Media Mentions

StockTwits View ARNA Stock Mentions - StockTwits PennyStocks View ARNA Stock Mentions - PennyStockTweets
Twitter View ARNA Stock Mentions - Twitter Invest Hub View ARNA Investment Forum News - Investor Hub
Yahoo View ARNA Stock Mentions - Yahoo! Message Board Seeking Alpha View ARNA Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ARNA - Insider Cow View Insider Transactions for ARNA - Insider Cow
CNBC View ARNA Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ARNA - OTC Markets
Yahoo View Insider Transactions for ARNA - Yahoo! Finance NASDAQ View Institutional Holdings for ARNA - NASDAQ

Stock Charts

FinViz View ARNA Stock Insight & Charts - StockCharts View ARNA Investment Charts -
BarChart View ARNA Stock Overview & Charts - BarChart Trading View View ARNA User Generated Charts - Trading View

Latest Financial News for ARNA

Arena Pharmaceuticals to Host R&D Day on October 4 in New York City
Posted on Friday September 21, 2018

SAN DIEGO, Sept. 21, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced that the Company will host an R&D Day to outline key catalysts and new information on the clinical programs for its potentially first- or best-in-class late-stage investigational compounds: etrasimod in inflammatory bowel disease (IBD), ralinepag in pulmonary arterial hypertension (PAH), and olorinab in visceral pain. The Company will also provide updates on its broader portfolio.

Arena Pharmaceuticals to Present at Upcoming Investor Conferences
Posted on Thursday September 20, 2018

A live audio webcast of the presentations will be available under the investor relations section of Arena's website at A replay of the presentations will be available for 30 days following the events. Arena Pharmaceuticals is focused on delivering novel, transformational medicines with optimized pharmacology and pharmacokinetics to patients globally.

Arena Pharmaceuticals Presents Preclinical Data for Olorinab at International Association for the Study of Pain World Congress
Posted on Monday September 17, 2018

"We are pleased to present data supporting olorinab's antinociceptive effects in visceral sensory pathways," said Preston Klassen, MD, MHS, Executive Vice President, Research and Development and Chief Medical Officer of Arena. "Through its full-agonism and selectivity, we believe olorinab may provide a novel therapeutic approach for sustained relief of visceral pain without psychotropic effects, potentially providing a new treatment option without the risk for dependence or abuse.

Today's Research Reports on Trending Tickers: Arena Pharmaceuticals and Emergent BioSolutions
Posted on Monday September 17, 2018

On Thursday, President Donald Trump instructed aides to carry on with $200 billion tariffs against Chinese goods. “Between high corporate profits, stock buybacks, and muted interest rates, there’s still an underlying bid to the market no matter how you slice it. Arena Pharmaceuticals' stock jumped 3.33% Friday, to close the day at $42.18.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.